Articles by Jim Hall - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jim Hall

A Decade (and 1/2) of Deals

As the industry focuses on late-stage deals, Big Pharma takes on the risks of compounds in preclinical development.
Oct 1, 2004

More than half the deals made by pharma are with companies based in the US, 28 percent in Europe, and 15 percent Japan.

ADVERTISEMENT

ADVERTISEMENT

Click here